Aryan Mishra: β-Thalassemia Analyzer – HPLC for Hemoglobinopathy Screening
Aryan Mishra, Sales Executive at Surana Enterprises, shared a post on LinkedIn:
“β-Thalassemia Analyzer: What Does It Actually Do?
A routine CBC can provide important clues, but evaluating β-thalassemia and other hemoglobinopathies may require detailed hemoglobin analysis.
Many dedicated systems use HPLC (High-Performance Liquid Chromatography) to separate and quantify different hemoglobin fractions.
Blood Sample leads to Separation, followed by Detection, Chromatogram, and Result.
Key parameters such as HbA₂ and HbF can provide valuable information during laboratory evaluation.
Why is this technology important?
- Carrier screening
- HbA₂ and HbF quantification
- Hemoglobin variant analysis
- Hemoglobinopathy screening
- Standardized laboratory workflow
Key takeaway: A diagnostic analyzer isn’t just a machine—it is a tool that helps laboratories generate clinically meaningful information.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question